|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
||
 
 |
|
|
|
Mr. O'Sullivan worked at both the New York and Sydney, Australia offices of Skadden, Arps, Slate, Meagher & Flom, prior to admission, where his work focused on project finance, international mergers and acquisitions and other cross-border transactions. He has also focused on healthcare and intellectual property matters, including: the defense of an immunoassay systems manufacturer against a governmental investigation; an internal investigation into the accounting practices of a multi-national pharmaceutical company; the defense of a pharmaceutical company against one of the largest products liability class action lawsuits in the country; as well as various transactions and disputes concerning copyrights, trademarks and patented technology. Mr. O'Sullivan is actively involved in the biotechnology industry in the United States and Australia. He is a member of the New York State Bar Association's Committee on Biotechnology and the Law and the American Bar Association's Committee on Biotechnology. He is also affiliated with a number of industry-specific organizations including the New York Biotechnology Association, Australia's Biotechnology Organisation, BioMelbourne Network and Lab to Wall Street. Mr. O'Sulllivan has a particular interest in the bioethical and regulatory issues raised by new technologies and is a member of the American Society for Bioethics and Humanities and the International Association of Bioethics. A graduate of the Benjamin N. Cardozo School of Law in New York, Mr. O'Sullivan is admitted to practice law before the Courts of the State of New York. Mr. O'Sullivan is also Of Counsel to Balestriere PLLC of New York. For further information on Balestriere PLLC please visit: www.balestriere.net.
See bio of John Balestriere > |
|
|
|
 |
|
|
|
|
|||
 |
|
 |
|
